We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

99 hedge funds and large institutions have $206M invested in Cue Health Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 37 increasing their positions, 10 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

270% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 10

79% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 19

47% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $1.82M

15% more funds holding

Funds holding: 8699 (+13)

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

45% less capital invested

Capital invested by funds: $371M → $206M (-$165M)

Holders
99
Holders Change
+13
Holders Change %
+15.12%
% of All Funds
1.67%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
34
Increased
37
Reduced
10
Closed
19
Calls
$2.68M
Puts
$1.82M
Net Calls
+$864K
Net Calls Change
+$1.26M
Name Holding Trade Value Shares
Change
Change in
Stake
KI
1
Koch Industries
Kansas
$42.2M
OC
2
Oakmont Corp
California
$31.3M
DCMIC
3
Decheng Capital Management III (Cayman)
Cayman Islands
$28.7M
JJ
4
Johnson & Johnson
New Jersey
$17.8M
BlackRock
5
BlackRock
New York
$17.1M +$25.3M +4,662,830 +686%
JPC
6
Jabodon PT Co
Nevada
$14.6M
Temasek Holdings
7
Temasek Holdings
Singapore
$10M
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.67M +$13.7M +2,522,091 +1,346%
State Street
9
State Street
Massachusetts
$4.49M +$6.39M +1,180,150 +532%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$3.27M +$4.32M +796,710 +355%
BL
11
Bleichroeder LP
New York
$3.2M
Goldman Sachs
12
Goldman Sachs
New York
$2.77M +$41.5K +7,662 +0.9%
Northern Trust
13
Northern Trust
Illinois
$2.27M +$3.31M +611,932 +630%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$2.08M +$3.24M +598,549 +1,197%
N
15
Nuveen
North Carolina
$1.66M +$2.62M +484,214 +1,475%
BRWA
16
B. Riley Wealth Advisors
Florida
$1.62M +$816K +150,705 +42%
MP
17
MSD Partners
New York
$1.26M
Bank of New York Mellon
18
Bank of New York Mellon
New York
$938K +$1.41M +260,355 +794%
Mirae Asset Global Investments
19
Mirae Asset Global Investments
South Korea
$912K +$1.54M +285,131 New
Charles Schwab
20
Charles Schwab
California
$758K +$1.11M +205,129 +648%
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
$713K +$1.21M +222,824 New
National Bank of Canada
22
National Bank of Canada
Quebec, Canada
$670K +$127K +23,400 +13%
Janus Henderson Group
23
Janus Henderson Group
United Kingdom
$595K +$1.01M +185,900 New
Renaissance Technologies
24
Renaissance Technologies
New York
$542K +$917K +169,282 New
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$486K +$742K +137,044 +925%

HLTH Hedge Fund Activity: Q2 2022 in Review

99 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q2 2022, worth a combined $206M — down 45% from $371M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new HLTH positions and 19 closed out — a net gain of 15 holders — while 37 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $25.3M. The largest seller was Capital World Investors, exiting entirely with an estimated $11.3M sold.

  • 99 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q2 2022, up from 86 in Q1 2022.
  • Funds reported $206M of Cue Health Inc. Common Stock stock for Q2 2022, down 45% quarter-over-quarter.
  • 34 funds opened new Cue Health Inc. Common Stock positions in Q2 2022 and 19 closed out, a net change of +15 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $25.3M added.
  • The largest Cue Health Inc. Common Stock seller in Q2 2022 was Capital World Investors, an estimated $11.3M sold.

Based on aggregated 13F filings for Q2 2022.